Abstract
Analysis of gene expression is a promising approach to understand tumor hypoxia and to relate biology to prognosis and response to therapy. Understanding the response to hypoxia of every component of the tumor mass is indispensable to understand the biology of the system. However, the plasticity and distribution of hypoxic areas make it difficult to gauge tumor hypoxia by combining the information of individual components. Global information on tumor gene expression revealed by the analysis of the transcriptome of the tumor mass provides a global view of the hypoxic status of the tissue. The global and analytic assessment of tumor hypoxia, revealed by the whole tumor mass or by its individual components, will be discussed with particular emphasis on tumor-infiltrating leukocytes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abeel T, Helleputte T, Van de PY et al (2010) Robust biomarker identification for cancer diagnosis with ensemble feature selection methods. Bioinformatics 26:392–398
Balsamo M, Manzini C, Pietra G, Raggi F, Blengio F, Mingari MC, Varesio l, Moretta l, Bosco MC, Vitale M (2013) Hypoxia downregulates the expression of activating receptors involved in NK cell-mediated target cell killing without affecting ADCC. Eur J Immunol. doi: 10.1002/eji.201343448 [Epub ahead of print]
Battaglia F, Delfino S, Merello E et al (2008) Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-{kappa}B. J Leukoc Biol 83:648–662
Ben Baruch A (2006) Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16:38–52
Benita Y, Kikuchi H, Smith AD et al (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res 37:4587–4602
Bennaceur K, Chapman J, Brikci-Nigassa L et al (2008) Dendritic cells dysfunction in tumour environment. Cancer Lett 272:186–196
Blengio F, Raggi F, Pierobon D et al (2013) The hypoxic environment reprograms the cytokine/chemokine expression profile of human mature dendritic cells. Immunobiology 218(1):76–89
Bosco MC, Varesio L (2010) Monocytic cell gene regulation by the hypoxic synovial environment in juvenile idiopathic arthritis: implications for disease pathogenesis. J Clin Rheumatol Musculoskel Med 1:47–55
Bosco MC, Varesio L (2012) Dendritic cell reprogramming by the hypoxic environment. Immunobiology 217:1241–1249
Bosco MC, Puppo M, Pastorino S et al (2004a) Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 172:1681–1690
Bosco MC, Reffo G, Puppo M et al (2004b) Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell Immunol 228:1–7
Bosco MC, Puppo M, Santangelo C et al (2006) Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 177:1941–1955
Bosco MC, Delfino S, Ferlito F et al (2008a) Hypoxic synovial environment and expression of macrophage inflammatory protein MIP-3a/CCL20 in Juvenile Idiopathic Arthritis. Arthritis Rheum 58:1833–1838
Bosco MC, Puppo M, Blengio F et al (2008b) Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration. Immunobiology 213:733–749
Bosco MC, Pierobon D, Blengio F et al (2011) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117:2625–2639
Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991–4995
Brand S (2009) Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut 58:1152–1167
Brown JM, William WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437–447
Buffa FM, Harris AL, West CM et al (2010) Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br J Cancer 102:428–435
Burke B, Giannoudis A, Corke KP et al (2003) Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163:1233–1243
Busk M, Horsman MR, Jakobsen S et al (2008) Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging 35:2294–2303
Caldwell CC, Kojima H, Lukashev D et al (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167:6140–6149
Carmeliet P, Dor Y, Herbert JM et al (1998) Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394:485–490
Carta L, Pastorino S, Melillo G et al (2001) Engineering of macrophages to produce IFN-gamma in response to hypoxia. J Immunol 166:5374–5380
Cavanagh LL, Von Andrian UH (2002) Travellers in many guises:The origins and destinations of dendritic cells. Immun Cell Biol 80:448–462
Chadwick W, Boyle JP, Zhou Y et al (2011) Multiple oxygen tension environments reveal diverse patterns of transcriptional regulation in primary astrocytes. PLoS One 6:e21638
Chan DA, Giaccia AJ (2007) Hypoxia, gene expression, and metastasis. Cancer Metastasis Rev 26:333–339
Chi JT, Wang Z, Nuyten DS et al (2006) Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 3:e47
Coffelt SB, Chen YY, Muthana M et al (2011) Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion. J Immunol 186:4183–4190
Colonna M, Nakajima H, Cella M (2000) A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin Immunol 12:121–127
Cornero A, Acquaviva M, Fardin P et al (2012) Design of a multi-signature ensemble classifier predicting neuroblastoma patients’ outcome. BMC Bioinformatics 13(Suppl 4):S13
Cramer T, Yamanishi Y, Clausen BE et al (2003) HIF-1a is essential for myeloid cell-mediated inflammation. Cell 112:645–657
Crowther M, Brown NJ, Bishop ET et al (2001) Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 70:478–490
Cummins EP, Taylor CT (2005) Hypoxia-responsive transcription factors. Pflugers Arch 450:363–371
de Visser KE, Coussens LM (2005) The interplay between innate and adaptive immunity regulates cancer development. Cancer Immunol Immunother 54:1143–1152
Eckert AW, Kappler M, Schubert J et al (2012) Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients. Oral Maxillofac Surg 16:189–196
Edsjo A, Holmquist L, Pahlman S (2007) Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 17:248–256
Elia AR, Cappello P, Puppo M et al (2008) Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol 84:1472–1482
Evans SM, Hahn S, Pook DR et al (2000) Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60:2018–2024
Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560–569
Fan C, Prat A, Parker JS et al (2011) Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures. BMC Med Genomics 4:3
Fang HY, Hughes R, Murdoch C et al (2009a) Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114:844–859
Fang HY, Hughes R, Murdoch C et al (2009b) Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114:844–859
Fardin P, Barla A, Mosci S et al (2009) The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines. BMC Genomics 10:474
Fardin P, Barla A, Mosci S et al (2010a) A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients. Mol Cancer 9:185
Fardin P, Cornero A, Barla A et al (2010b) Identification of multiple hypoxia signatures in neuroblastoma cell lines by l(1)-l(2) regularization and data reduction. J Biomed Biotechnol 2010:878709
Fink T, Ebbesen P, Koppelhus U et al (2003) Natural killer cell-mediated basal and interferon-enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions. Scand J Immunol 58:607–612
Gaber T, Haupl T, Sandig G et al (2009) Adaptation of human CD4+ T cells to pathophysiological hypoxia: a transcriptome analysis. J Rheumatol 36:2655–2669
Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4:941–952
Ghadjar P, Rubie C, Aebersold DM et al (2009) The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 125:741–745
Gray LH, Conger AD, Ebert M et al (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648
Greco O, Scott S (2007) Tumor hypoxia and targeted gene therapy. Int Rev Cytol 257:181–212
Grimshaw MJ, Balkwill FR (2001) Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation—a potential mechanism. Eur J Immunol 31:480–489
Gross MW, Karbach U, Groebe K et al (1995) Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int J Cancer 61:567–573
Haibe-Kains B, Desmedt C, Piette F et al (2008) Comparison of prognostic gene expression signatures for breast cancer. BMC Genomics 9:394
Halle C, Andersen E, Lando M et al (2012) Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res 72:5285–5295
Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47
Ho CC, Liao WY, Wang CY et al (2008) TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 177:763–770
Hoeben BA, Kaanders JH, Franssen GM et al (2010) PET of hypoxia with 89Zr-labeled cG250-F(ab’)2 in head and neck tumors. J Nucl Med 51:1076–1083
Holland JP, Lewis JS, Dehdashti F (2009) Assessing tumor hypoxia by positron emission tomography with Cu-ATSM. Q J Nucl Med Mol Imaging 53:193–200
Hwang J, Kim CW, Son KN et al (2004) Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett 570:47–51
Imhof BA, Aurrand-Lions M (2004) Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 4:432–444
Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105–120
Jogi A, Vallon-Christersson J, Holmquist L et al (2004) Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res 295:469–487
Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984–993
Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–650
Knowles HJ, Harris AL (2007) Macrophages and the hypoxic tumour microenvironment. Front Biosci 12:4298–4314
Kong T, Eltzschig HK, Karhausen J et al (2004) Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc Natl Acad Sci U S A 101:10440–10445
Kulbe H, Levinson NR, Balkwill F et al (2004) The chemokine network in cancer–much more than directing cell movement. Int J Dev Biol 48:489–496
Lamagna C Aurrand-Lions M, Imhof BA (2006) Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 80:705–713
Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106:263–266
Lewis C, Murdoch C (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol 167:627–635
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612
Lewis CE, De Palma M, Naldini L (2007) Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res 67:8429–8432
Li Q, Withoff S, Verma IM (2005) Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26:318–325
Liao R, Sun TW, Yi Y et al (2012) Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci 103:984–992
Lin A, Schildknecht A, Nguyen LT et al (2010) Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth. Immunol Lett 127:77–84
Lin KW, Jacek T, Jacket R (2006) Dendritic cells heterogeneity and its role in cancer immunity. Cancer Res Ther 2:35–40
Lin Q, Yun Z (2010) Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Cancer Biol Ther 9:949–956
Louis CA, Reichner JS, Henry WL, Jr. et al (1998) Distinct arginase isoforms expressed in primary and transformed macrophages: regulation by oxygen tension. Am J Physiol 274:R775–R782
Lu X, Kang Y (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16:5928–5935
Lukashev D, Klebanov B, Kojima H et al (2006) Cutting edge: hypoxia-inducible factor 1 and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177:4962–4965
Malenstein H, Gevaert O, Libbrecht L et al (2010) A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma. Clin Cancer Res 16:4278–4288
Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22:231–237
Mantovani A, Allavena P, Sozzani S et al (2004) Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol 14:155–160
Mees G, Dierckx R, Vangestel C et al (2009) Molecular imaging of hypoxia with radiolabelled agents. Eur J Nucl Med Mol Imaging 36:1674–1686
Moon EJ, Brizel DM, Chi JT et al (2007) The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 9:1237–1294
Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23:255–259
Moser M, Murphy KM (2000) Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1:199–205
Murat A, Migliavacca E, Hussain SF et al (2009) Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PLoS One 4:e5947
Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104:2224–2234
Murdoch C, Tazzyman S, Webster S et al (2007) Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J Immunol 178:7405–7411
Muselli M, Ferrari E (2011) Coupling Logical Analysis of Data and Shadow Clustering for Partially Defined Positive Boolean Function Reconstruction. IEEE Transactions on Knowledge Data Engineering 23:37–50
Muthana M, Giannoudis A, Scott SD et al (2011) Use of macrophages to target therapeutic adenovirus to human prostate tumors. Cancer Res 71:1805–1815
Neumann AK, Yang J, Biju MP et al (2005) Hypoxia inducible factor 1 alpha regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A 102:17071–17076
Nistala K, Moncrieffe H, Newton KR et al (2008) Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 58:875–887
Nizet V, Johnson RS (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9:609–617
Nuyten DS, Hastie T, Chi JT et al (2008) Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification. Eur J Cancer 44:2319–2329
Palazon A, Aragones J, Morales-Kastresana A et al (2012) Molecular pathways: hypoxia response in immune cells fighting or promoting cancer. Clin Cancer Res 18:1207–1213
Palucka KA, Taquet N, SanchezChapuis F et al (1998) Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 160:4587–4595
Perez-Perri JI, Acevedo JM, Wappner P (2011) Epigenetics: new questions on the response to hypoxia. Int J Mol Sci 12:4705–4721
Peyssonnaux C, Datta V, Cramer T et al (2005) HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115:1806–1815
Pierobon D, Bosco MC, Blengio F et al (2013) Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. Eur J Immunol 43:949–966
Pietra G, Manzini C, Rivara S et al (2012) Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 72:1407–1415
Platonova S, Cherfils-Vicini J, Damotte D et al (2011) Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 71:5412–5422
Pocock R (2011) Invited review: decoding the microRNA response to hypoxia. Pflugers Arch 461:307–315
Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78
Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39–51
Raber P, Ochoa AC, Rodriguez PC (2012) Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives. Immunol Invest 41:614–634
Rahat MA, Marom B, Bitterman H et al (2006) Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol 79:706–718
Raleigh JA, Chou SC, Arteel GE et al (1999) Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151:580–589
Rama I, Brune B, Torras J et al (2008) Hypoxia stimulus: An adaptive immune response during dendritic cell maturation. Kidney Int 73:816–825
Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678–685
Ricciardi A, Elia AR, Cappello P et al (2008) Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res 6:175–185
Rius J, Guma M, Schachtrup C et al (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807–811
Rodrigues LR, Teixeira JA, Schmitt FL et al (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 16:1087–1097
Roiniotis J, Dinh H, Masendycz P et al (2009) Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 182:7974–7981
Rossi M, Young JW (2005) Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 175:1373–1381
Saeys Y, Inza I, Larranaga P (2007) A review of feature selection techniques in bioinformatics. Bioinformatics 23:2507–2517
Sceneay J, Chow MT, Chen A et al (2012) Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res 72:3906–3911
Schioppa T, Uranchimeg B, Saccani A et al (2003) Regulation of the Chemokine Receptor CXCR4 by Hypoxia. J Exp Med 198:1391–1402
Schmieder A, Michel J, Schonhaar K et al (2012) Differentiation and gene expression profile of tumor-associated macrophages. Semin Cancer Biol 22:289–297
Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331:1565–1570
Schutyser E, Struyf S, Van Damme J (2003) The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14:409–426
Seigneuric R, Starmans MH, Fung G et al (2007) Impact of supervised gene signatures of early hypoxia on patient survival. Radiother Oncol 83:374–382
Semenza GL (2009) Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19:12–16
Semenza GL (2011) Oxygen sensing, homeostasis, and disease. N Engl J Med 365:537–547
Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33:207–214
Sharif O, Knapp S (2008) From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 213:701–713
Sica A, Bronte V (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117:1155–1166
Sica A, Saccani A, Bottazzi B et al (2000) Defective expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in macrophages associated with human ovarian carcinoma. J Immunol 164:733–738
Sica A, Melillo G, Varesio L (2011) Hypoxia: a double-edged sword of immunity. J Mol Med 89:657–665
Sitkovsky M, Lukashev D (2008) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5:712–721
Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419–426
Strieter RM, Burdick MD, Mestas J et al (2006) Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42:768–778
Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PNAS 102:15545–15550
Sun J, Zhang Y, Yang M et al (2010) Hypoxia induces T-cell apoptosis by inhibiting chemokine C receptor 7 expression: the role of adenosine receptor A(2). Cell Mol Immunol 7:77–82
Synnott JM, Guida A, Mulhern-Haughey S et al (2010) Regulation of the hypoxic response in Candida albicans. Eukaryot Cell 9:1734–1746
Tan AC, Gilbert D (2003) Ensemble machine learning on gene expression data for cancer classification. Appl Bioinformatics 2:S75–S83
Thiel M, Caldwell CC, Kreth S et al (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2:e853
Toustrup K, Sorensen BS, Nordsmark M et al (2011) Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer. Cancer Res 71:5923–5931
Toustrup K, Sorensen BS, Alsner J et al (2012a) Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy. Semin Radiat Oncol 22:119–127
Toustrup K, Sorensen BS, Lassen P et al (2012b) Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck. Radiother Oncol 102:122–129
Turner L, Scotton C, Negus R et al (1999) Hypoxia inhibits macrophage migration. Eur J Immunol 29:2280–2287
Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9(Suppl 5):10–17
Vaupel P, Kelleher DK (2013) Blood flow and oxygenation status of prostate cancers. Adv Exp Med Biol 765:299–305
Vaupel P, Thews G (1974) PO2 distribution in tumor tissue of DS-carcinosarcoma. Oncology 30:475–484
Vicari AP, Caux C, Trinchieri G (2002) Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 12:33–42
Vulcano M, Struyf S, Scapini P et al (2003) Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 170:3843–3849
Walmsley SR, Print C, Farahi N et al (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201:105–115
Watson JA, Watson CJ, McCann A et al (2010) Epigenetics, the epicenter of the hypoxic response. Epigenetics 5:293–296
Wedderburn LR, Robinson N, Patel A et al (2000) Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 43:765–774
Wenger RH, Stiehl DP, Camenisch G (2005) Integration of oxygen signaling at the consensus HRE. Sci STKE 2005:re12
White JR, Harris RA, Lee SR et al (2004) Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 83:1–8
Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11:393–410
Winter SC, Buffa FM, Silva P et al (2007) Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 67:3441–3449
Wu J, Li J, Salcedo R et al (2012) The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 72:3977–3986
Xu L, Tan AC, Winslow RL et al (2008) Merging microarray data from separate breast cancer studies provides a robust prognostic test. BMC Bioinformatics 9:125
Xu M, Mizoguchi I, Morishima N et al (2010) Regulation of antitumor immune responses by the IL-12 family cytokines, IL-12, IL-23, and IL-27. Clin Dev Immunol 2010:832454
Yang M, Ma C, Liu S et al (2009) Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin. Immunology 128:e237–e249
Yun S, Lee SH, Yoon SR et al (2011) Oxygen tension regulates NK cells differentiation from hematopoietic stem cells in vitro. Immunol Lett 137:70–77
Zampetaki A, Mitsialis SA, Pfeilschifter J et al (2004) Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/p44 and PI3 kinase pathways. FASEB J 18:1090–1092
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bosco, M., Varesio, L. (2014). Hypoxia and Gene Expression. In: Melillo, G. (eds) Hypoxia and Cancer. Cancer Drug Discovery and Development. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9167-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9167-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9166-8
Online ISBN: 978-1-4614-9167-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)